APA (7th ed.) Citation

Allouch, A., Voisin, L., Zhang, Y., Raza, S. Q., Lecluse, Y., Calvo, J., . . . Perfettini, J. (2022). CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia. Nature communications, 13(1), 6739-16. https://doi.org/10.1038/s41467-022-34548-3

Chicago Style (17th ed.) Citation

Allouch, Awatef, et al. "CDKN1A Is a Target for Phagocytosis-mediated Cellular Immunotherapy in Acute Leukemia." Nature Communications 13, no. 1 (2022): 6739-16. https://doi.org/10.1038/s41467-022-34548-3.

MLA (9th ed.) Citation

Allouch, Awatef, et al. "CDKN1A Is a Target for Phagocytosis-mediated Cellular Immunotherapy in Acute Leukemia." Nature Communications, vol. 13, no. 1, 2022, pp. 6739-16, https://doi.org/10.1038/s41467-022-34548-3.